OBJECTIVE	This prospective , randomized , controlled clinical trial tested the hypothesis that treatment of infrapopliteal arterial occlusive lesions with an everolimus-eluting stent ( Xience V ) would provide superior patency to treatment with a bare-metal stent ( Multi-Link Vision ) .\